šŸ”µ Salzmann Nodular Degeneration: A Quiet Culprit in Ocular Surface Disease

Salzmann Nodular Degeneration (SND) might not be the most common topic in daily ophthalmic practice, but for the seasoned clinician or FRCOphth candidate, it’s an essential entity to recognize. Subtle in appearance yet significant in impact, SND is a classic example of how chronic ocular surface stress can manifest in the corneal stroma.

Let’s unpack this condition from pathogenesis to management, with clinical pearls along the way.

šŸ‘ļø What Is Salzmann Nodular Degeneration?

SND is a non-inflammatory, slowly progressive degenerative condition of the cornea, characterized by elevated bluish-white subepithelial nodules, typically located in the mid-peripheral to peripheral cornea. These nodules are often bilateral and more commonly seen in middle-aged to elderly women.

šŸ”¬ Pathophysiology

The exact etiology is not fully understood, but SND is thought to result from:

  • Chronic ocular surface irritationĀ or inflammation
  • Disruption inĀ epithelial-stromal interactions
  • Abnormal extracellular matrix deposition andĀ Bowman’s layer replacement by fibrous tissue

It may occur idiopathically or secondary to:

  • Dry eye disease
  • Meibomian gland dysfunction
  • Chronic blepharitis
  • Previous trauma or surgeryĀ (e.g., LASIK, PK)
  • Inflammatory conditionsĀ like vernal or atopic keratoconjunctivitis

šŸ”Ž Clinical Features

  • Nodules: Elevated, bluish-white to grey nodules, 1–2 mm in size
  • Location: Superficial stroma, beneath an intact epithelium, commonly in the mid-peripheral cornea (between 3 and 9 o’clock positions)
  • Symptoms:
    • OftenĀ asymptomatic
    • May present withĀ foreign body sensation, glare, orĀ reduced visionĀ if nodules encroach upon the visual axis

🧪 Diagnostic Tools

  • Slit-lamp biomicroscopy: Key for identifying the nodules
  • Anterior Segment OCT: Shows hyperreflective subepithelial lesions
  • Topography: May reveal irregular astigmatism or localized flattening
  • Histology (if excised): Absence of Bowman’s layer with subepithelial fibrosis and hyaline degeneration

šŸ› ļø Differential Diagnoses

  • Band keratopathy
  • Salzmann’s degeneration vs. spheroidal degeneration
  • Nodular episcleritis or phlyctenulosis (if adjacent to limbus)
  • Intraepithelial neoplasia (very different clinically, but worth ruling out)

šŸ’Š Management Options

Conservative

  • LubricantsĀ (preservative-free)
  • Lid hygieneĀ andĀ MGD management
  • Anti-inflammatory drops: Mild topical steroids or cyclosporine in selected cases
  • Treat underlying surface diseaseĀ (e.g., blepharitis, VKC)

Surgical

Indicated when vision is affected or nodules are symptomatic:

  • Superficial Keratectomy (SK): Mainstay for central nodules or visual symptoms
  • Phototherapeutic Keratectomy (PTK): Improves surface smoothness and vision
  • Lamellar or Penetrating Keratoplasty: Rarely needed

ā³ Prognosis and Recurrence

  • Visual prognosis isĀ generally goodĀ after SK or PTK
  • RecurrenceĀ is possible, especially if the underlying cause is not addressed
  • Long-termĀ ocular surface managementĀ is key to preventing recurrence

šŸ“ FRCOphth Tip

Salzmann’s nodular degeneration may feature in ocular surface disordersexternal eye disease, or even as a subtle image-based station. If a clinical photo shows elevated nodules in an elderly patient with dry eye or rosacea history—think SND!

Don’t forget: management includes not just removing the nodules but also treating the surface disease that led to them.

šŸ“š Suggested Reading

  • Krachmer et al.Ā CorneaĀ textbook
  • Review articles in BJO or Eye Journal
  • Anterior segment OCT case series

šŸ’¬ Final Thoughts

Salzmann Nodular Degeneration is a reminder that even non-inflammatory conditions can affect vision and quality of life. A good ophthalmologist doesn’t just remove the nodules—they investigate and address the root cause. That’s the art of practice—and the heart of our exams.